Monte Rosa Therapeutics scores $32.5m Series A
Boston-based Monte Rosa Therapeutics, a biotechnology company, has raised $32.5 million in Series A funding.
Boston-based Monte Rosa Therapeutics, a biotechnology company, has raised $32.5 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination